Alamar Biosciences, Inc.
- ALMR
- NASDAQ
- Biotechnology
- Proteomics
- Life Science Tools
$25.28
Today −7.80%Quote Oct 16, 2026, 08:00 PM UTC
−21.02%over the last month
Max drawdown −38.3%From 1-month high −33.7%3 months +5.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$1.75B
Quote Oct 16
Next earnings
Nov 3
Expected, not confirmed
Analyst target
$33.50
+32.5% from here
Floor
$25.12
0.6% below price
Where the price sits
2 analysts
Analyst range, low to high
$32.00$35.00
- Price $25.28
- Resistance $26.93–$27.20
- Consensus $33.50
The price is just above its floor. Analysts' average target sits about 33% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ALMRPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q2 2026 revenue $29.4M
- Consumables$15.5M52.6%
- Instruments$7.8M26.5%
- Service$6.2M20.9%
Industry
Biotechnology
Employees
222